Apeloa Pharmaceutical

Apeloa Pharmaceutical is one of the...

• CSI 500.

Apeloa Pharmaceutical is a company listed under the stock ticker 000739 (CN).

View the org chart displaying its 7 main executives

Most searched biographies at Apeloa Pharmaceutical

• Xinliang Xu, Chief Executive Officer and Director
• Ling Chen, Independent Director
• Weiguang Pan, Independent Director

Create your alert
to follow the executive moves at Apeloa Pharmaceutical.

Apeloa Pharmaceutical has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Apeloa Pharmaceutical

Social media about Apeloa Pharmaceutical

• Apeloa Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Apeloa Pharmaceutical on LinkedIn, Twitter & YouTube

Contact by email its executives including Xinliang Xu

Call Apeloa Pharmaceutical at +86 579 ...

View the org chart

Register to receive your alert

Report an error